Characterization of the Neuroendocrine Tumor Immune Microenvironment

Pancreas
Annacarolina Da SilvaMatthew H Kulke

Abstract

The immune environment and the potential for neuroendocrine tumors (NETs) to respond to immune checkpoint inhibitors remain largely unexplored. We assessed immune checkpoint marker expression, lymphocytic infiltrate, and associated mutational profiles in a cohort of small intestine and pancreatic NETs. We assessed expression of PDCD1 (PD-1), CD274 (PD-L1), and PDCD1LG2 (PD-L2) in archival tissue from 64 small intestine (SINETs) and 31 pancreatic NETs (pNET). We additionally assessed T-cell infiltrates, categorizing T-cell subsets based on expression of the T-cell markers CD3, CD8, CD45RO (PTPRC), or FOXP3. Finally, we explored associations between immune checkpoint marker expression, lymphocytic infiltrate, and tumor mutational profiles. Expression of PD-1 or PD-L1 in small intestine or pancreatic NET was rare, whereas expression of PD-L2 was common in both NET subtypes. T-cell infiltrates were more abundant in pNET than in SINET. We found no clear associations between immune checkpoint marker expression, immune infiltrates, and specific mutational profile within each tumor type. Our findings provide an initial assessment of the immune environment of well-differentiated NETs. Further studies to define the immunologic difference...Continue Reading

References

Feb 27, 2001·Nature Immunology·Y LatchmanG J Freeman
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Nov 19, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Steven C KatzLaura H Tang
Feb 11, 2011·The New England Journal of Medicine·Eric RaymondPhilippe Ruszniewski
Feb 11, 2011·The New England Journal of Medicine·James C YaoUNKNOWN RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group
Feb 12, 2013·Nature Biotechnology·Kristian CibulskisGad Getz
May 2, 2013·Therapeutic Advances in Medical Oncology·John Stagg, Bertrand Allard
Nov 5, 2013·Nature Genetics·Joshua M FrancisMatthew Meyerson
Jul 12, 2014·The New England Journal of Medicine·Martyn E CaplinUNKNOWN CLARINET Investigators
Jan 15, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anne M SchultheisReinhard Buettner
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A PostowJedd D Wolchok
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jun 18, 2015·Cancer Immunology Research·Sarah DerksAdam J Bass
Sep 12, 2015·Science·Eliezer M Van AllenLevi A Garraway
Oct 17, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Antonio CallesPasi A Jänne
Dec 26, 2015·Lancet·James C YaoUNKNOWN RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group
Mar 10, 2016·Journal of Cancer·Seung Tae KimYoung Suk Park
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaretha G M RoemerMargaret A Shipp
May 7, 2016·Cell Reports·Marios GiannakisLevi A Garraway
Oct 28, 2016·OncoTargets and Therapy·Yangwei FanYinying Wu
Feb 16, 2017·Nature·Aldo ScarpaSean M Grimmond
Jun 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer H YearleyTerrill McClanahan
Aug 25, 2017·Molecular Cancer Therapeutics·Aaron M GoodmanRazelle Kurzrock
Oct 7, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Thomas A AdamsAgnieszka K Witkiewicz
Oct 17, 2017·Frontiers in Oncology·Charissa A C JessurunRosalie M Luiten

❮ Previous
Next ❯

Citations

Nov 8, 2018·Endocrine-related Cancer·M CivesD Coppola
Apr 15, 2020·The Journal of Clinical Endocrinology and Metabolism·Wu-Hu ZhangLiang Liu
Sep 4, 2020·World Journal of Gastrointestinal Oncology·Monjur Ahmed
Jun 2, 2020·World Journal of Gastroenterology : WJG·Zu-Yi MaBao-Hua Hou
Jan 26, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan StrosbergJulien Hadoux
Feb 5, 2021·Frontiers in Endocrinology·Praveen Dilip ChataniSamira Mercedes Sadowski
Mar 1, 2021·Current Treatment Options in Oncology·Chiara BorgaMatteo Fassan
Apr 1, 2021·Current Treatment Options in Oncology·Alejandro Garcia-AlvarezJaume Capdevila
Apr 15, 2021·Reviews in Endocrine & Metabolic Disorders·Manuela AlbertelliDiego Ferone
Aug 24, 2019·Biochimica Et Biophysica Acta. Reviews on Cancer·Wu-Hu ZhangLiang Liu
May 1, 2021·Cancers·Anna La SalviaRocío Garcia-Carbonero
May 27, 2021·Japanese Journal of Clinical Oncology·Susumu HijiokaJunji Furuse
May 12, 2021·Current Opinion in Oncology·Christiane Jungels, Amélie Deleporte
Sep 3, 2021·Cancer Immunology, Immunotherapy : CII·Christo KoleDimitrios Schizas
Jan 31, 2019·Neuroendocrinology·Mauro CivesFranco Silvestris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.